- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04062968
Video Education for Prenatal Testing Choices
The Effect of Standardized Video Education on Prenatal Genetic Testing Choices, Decisional Conflict, and Decisional Regret
Studieoversigt
Detaljeret beskrivelse
This is a prospective randomized trial of video education on prenatal testing vs. usual care, with the goal to assess women's prenatal testing choices, understanding of testing options and decisional conflict and regret. Participants will be recruited from a convenience sample of patients presenting for prenatal care at Naval Medical Center San Diego (NMCSD).
While receiving prenatal care at NMCSD, all women are offered the option of screening for aneuploidy (serum screen (with or without nuchal translucency ultrasound) or cell free DNA testing) or diagnostic testing (chorionic villous sampling or amniocentesis) or no testing in pregnancy.
After providing consent, participants will be randomized to video education or usual care. Randomization will be completed using a random number table. Women randomized to the intervention group (video education) will view the prenatal screening video made by the Genetic Support Foundation and the Washington Department of Health, the 4.5 minute video "How to Decide About Prenatal Genetic Testing," available at: https://www.geneticsupportfoundation.org/genetics-and-you/pregnancy-and-genetics/prenatal-genetic-testing-videos .7 They will then complete the study related surveys at their initial obstetric visit. The educational video was created with input from clinicians including licensed genetic counselors, obstetricians, maternal fetal medicine physicians, and patients. Extensive testing and reviewing was completed to ensure adequate comprehension by a wide range of audiences and minimize counseling bias. Women randomized to the control group will receive routine prenatal care with no additional study intervention other than completion of the study related surveys at baseline (initial prenatal testing). Current national guidelines recommend offering all women prenatal diagnosis and prenatal screening at the beginning of the pregnancy.1
The primary outcome for this study will be screening uptake rates, and will be based on review of the patient's electronic medical record. Secondary outcomes will include invasive diagnostic test rates, participant knowledge about testing (as assessed using the Maternal Serum Screening Knowledge Questionnaire,2 and decisional conflict (as assessed by the Decisional Conflict Scale) and decisional regret (as assessed by the Decision Regret Scale). These assessments will be conducted at time of prenatal testing (< 20 weeks). (Appendix A)
The study questionnaire will include a check box for participants to indicate if they would be willing to participate in a follow on qualitative study to assess participant's personal experience related to their method of education about prenatal testing. This component of the study will aim to determine personal and social reasoning behind their decisions, and to further explore their experience, beliefs and behaviors. Interested participants from each group (both intervention and control) will be contacted to arrange a telephone or in person interview. (Appendix C) Participants will be interviewed in person or over the phone.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
San Diego, California, Forenede Stater, 92134
- Naval Medical Center San Diego
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Greater than or equal to 18 years of age
- Gestational age less than or equal to 20 weeks
- Singleton gestation
- Not completed aneuploidy screening in this pregnancy
- Available to watch the 15 minute video
- Ability to read, write, and understand English
Exclusion Criteria:
- Pregnant women not eligible for care at Military Treatment Facility
- Less than 18 years of age
- Gestational age greater than 20 weeks
- Multiple gestation
- Aneuploidy testing in current pregnancy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Video education
Women randomized to the intervention group (video education) will view the prenatal screening video made by the Genetic Support Foundation and the Washington Department of Health, the 4.5 minute video "How to Decide About Prenatal Genetic Testing," available at: https://www.geneticsupportfoundation.org/genetics-and-you/pregnancy-and-genetics/prenatal-genetic-testing-videos .7
They will then complete the study related surveys at their initial obstetric visit.
|
Prenatal screening video made by the Genetic Support Foundation and the Washington Department of Health, the 4.5 minute video "How to Decide About Prenatal Genetic Testing," available at: https://www.geneticsupportfoundation.org/genetics-and-you/pregnancy-and-genetics/prenatal-genetic-testing-videos .
|
Ingen indgriben: Usual care
Women randomized to the control group will receive routine prenatal care with no additional study intervention other than completion of the study related surveys at baseline (initial prenatal testing).
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
screening uptake rates
Tidsramme: 24-36 weeks gestation
|
Genetic screening
|
24-36 weeks gestation
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Invasive diagnostic test rates
Tidsramme: 24-36 weeks gestation
|
Diagnostic testing such as Chorinonic Villus Sampling and amniocentesis
|
24-36 weeks gestation
|
Participant knowledge about prenatal testing
Tidsramme: up to 20 weeks gestation
|
Assessed by using the Maternal Serum Screening knowledge Questionnaire.
Scores range from 0 to 15, reflecting the number of correct answers.
A score of zero would indicate zero correct answers, where a score of 15 would indicate all answers were correct.
Higher scores are considered better outcome indicating higher knowledge.
|
up to 20 weeks gestation
|
Decisional conflict
Tidsramme: up to 20 weeks gestation
|
Assessed by the Decisional Conflict Scale.
Questions are scored on a Likert scale of 1 to 5, with 1 equating to Strongly Agree and 5 equating to Strongly Disagree.
Thus, lower scores indicate lower decisional conflict.
Subscale Decisional Uncertainty score range 3 to 15. Subscale Percieved Effective Decision range 4 to 20.
|
up to 20 weeks gestation
|
Decisonal regret
Tidsramme: up to 20 weeks gestation
|
Assessed by the Decisional Regret Scale.
Questions are scored on a Likert scale of 1 to 5, with 1 equating to Strongly Agree and 5 equating to Strongly Disagree.
Thus, lower scores indicate lower decisional regret.
Decisional Regret scores range 0 to 100.
|
up to 20 weeks gestation
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- NMCSD.2016.0070
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Graviditet
-
King's College Hospital NHS TrustEuropean Association for the Study of the LiverRekrutteringCirrhose, lever | HELLP syndrom | Intrahepatisk kolestase af graviditet | Graviditetssygdom | AFLP - Acute Fatty Lever of PregnancyDet Forenede Kongerige
Kliniske forsøg med Video education
-
Ozum Cetinkaya ErenPamukkale University; Akdeniz UniversityAfsluttetPatienttilfredshed | Dagliglivets aktiviteter | Total hofteudskiftning | PatientuddannelseKalkun
-
University of ChicagoAfsluttetKronisk obstruktiv lungesygdom | AstmaForenede Stater
-
Thomas Jefferson UniversityRekrutteringProstata karcinomForenede Stater
-
Universidade Federal de Sao CarlosAfsluttet
-
Tokat Gaziosmanpasa UniversityAfsluttetStigmatisering | Funktionalitet | Peer Support | Kroniske psykiske lidelser | Træning i psykosociale færdigheder | IndsigtKalkun
-
Bilecik Seyh Edebali UniversitesiAfsluttetBrug af Flipped Classroom Model med sygeplejestuderendeKalkun
-
Centers for Disease Control and PreventionAfsluttetHIV-infektioner | Hepatitis CForenede Stater
-
Thomas Jefferson UniversityAfsluttetHæmatopoietisk og lymfoid celle-neoplasma | Ondartet fast neoplasmaForenede Stater
-
Rutgers, The State University of New JerseyRekrutteringMiljøeksponering | Udvalg af madForenede Stater
-
University of Nevada, Las VegasSt. Ambrose UniversityAfsluttetLændesmerter | Smerte, kronisk | Smerter, RygForenede Stater